Profil
Magdalena Tharaldsen is currently the Director of International Business Development at Calmark Sweden AB since 2020.
Prior to this, she worked as the Director of Business Development at MediRox AB from 2015 to 2020.
Postes actifs de Magdalena Tharaldsen
| Sociétés | Poste | Début |
|---|---|---|
| CALMARK SWEDEN AB | Corporate Officer/Principal | 01/08/2020 |
Anciens postes connus de Magdalena Tharaldsen
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIROX AB | Corporate Officer/Principal | 01/08/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden. | Health Technology |
Calmark Sweden AB
 Calmark Sweden AB Medical SpecialtiesHealth Technology Calmark Sweden AB is a medical technology company, which engages in the development of a point-of-care (POC) analysis method with easier and faster sampling of medical conditions in newborns. It is composed of a reader and a disposable product that is placed into the reader during measurement. The company was founded by Anders Mathias Karlsson and Sofia Margareta Hiort af Ornäs in 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
